betahistine dihydrochloride 16mg tablets tablets
accord healthcare limited - betahistine (betahistine dihydrochloride) - tablets - 16mg
betahistine dihydrochloride 8mg tablets tablets
accord healthcare limited - betahistine (betahistine dihydrochloride) - tablets - 8mg
betahistine dihydrochloride 8mg tablets tablets
accord healthcare limited - betahistine (betahistine dihydrochloride) - tablets - 8mg
finasteride 5mg film-coated tablets tablets film-coated
accord healthcare limited - finasteride - tablets film-coated - 5mg
metotrexat astron 50 mg/ml injektionsvätska, lösning i förfylld spruta
metastron
eldan electronic instruments co ltd - strontium (89sr) chloride - solution for injection - strontium (89sr) chloride 150 mbq / 4 ml - strontium (89sr) chloride - strontium (89sr) chloride - adjunct and alternative to external beam radiotherapy for palliation of pain from bone metastases secondary to prostatic carcinoma at the stage of hormone therapy failure.
metastron strontium(89sr) chloride 150 mbq/4ml injection
ge healthcare australia pty ltd - strontium(89sr) chloride, quantity: 37 mbq/ml - injection, solution - excipient ingredients: strontium chloride; water for injections - indications as at 20 may 2005 : for the palliation of pain from sclerotic bone metastases secondary to prostate carcinoma in patients who have not responded, or who are no longer responding to conventional therapies, including external beam radiotherapy. as an alternative to external beam therapy for the palliation of pain from bone metastases secondary to prostatic carcinoma at the stage of hormone therapy failure.
naproxen 250mg tablets tablets
accord healthcare limited - naproxen - tablets - 250mg
naproxen 500mg tablets tablets
accord healthcare limited - naproxen - tablets - 500mg
bosentan astron bosentan (as monohydrate) 62.5 mg film-coated tablets blister pack
accord healthcare pty ltd - bosentan monohydrate, quantity: 64.54 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: povidone; maize starch; sodium starch glycollate type a; pregelatinised maize starch; purified water; magnesium stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan astron is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.